Chr. Hansen Holding A/S

CPSE:CHR Stock Report

Market Cap: DKK 72.3b

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

Chr. Hansen Holding Valuation

Is CHR undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CHR when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: CHR (DKK549.6) is trading above our estimate of fair value (DKK213.49)

Significantly Below Fair Value: CHR is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for CHR?

Key metric: As CHR is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for CHR. This is calculated by dividing CHR's market cap by their current earnings.
What is CHR's PE Ratio?
PE Ratio42.8x
Earnings€227.00m
Market Cap€9.71b

Price to Earnings Ratio vs Peers

How does CHR's PE Ratio compare to its peers?

The above table shows the PE ratio for CHR vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average34.4x
NSIS B Novonesis
93.8x30.7%DKK 197.8b
AKZA Akzo Nobel
16.9x12.0%€9.5b
6988 Nitto Denko
12.5x2.1%JP¥1.7t
002001 Zhejiang NHU
14.6x9.3%CN¥66.7b
CHR Chr. Hansen Holding
42.8xn/aDKK 72.3b

Price-To-Earnings vs Peers: CHR is expensive based on its Price-To-Earnings Ratio (42.8x) compared to the peer average (23.9x).

Price to Earnings Ratio vs Industry

How does CHR's PE Ratio compare vs other companies in the European Chemicals Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
CHR 42.8xIndustry Avg. 17.1xNo. of Companies11PE01224364860+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: CHR is expensive based on its Price-To-Earnings Ratio (42.8x) compared to the European Chemicals industry average (12.9x).

Price to Earnings Ratio vs Fair Ratio

What is CHR's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CHR PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio42.8x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate CHR's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst CHR forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Currentn/a
DKK 543.91
0%
7.7%DKK 619.79DKK 484.78n/a7
Nov ’25n/a
DKK 543.91
0%
7.7%DKK 619.79DKK 484.78n/a7
Oct ’25n/a
DKK 543.91
0%
7.7%DKK 619.79DKK 484.78n/a7
Sep ’25n/a
DKK 543.91
0%
7.7%DKK 619.79DKK 484.78n/a7
Aug ’25n/a
DKK 543.91
0%
7.7%DKK 619.79DKK 484.78n/a7
Jul ’25n/a
DKK 543.91
0%
7.7%DKK 619.79DKK 484.78n/a7
Jun ’25n/a
DKK 543.91
0%
7.7%DKK 619.79DKK 484.78n/a7
May ’25n/a
DKK 543.91
0%
7.7%DKK 619.79DKK 484.78n/a7
Apr ’25n/a
DKK 543.91
0%
7.7%DKK 619.79DKK 484.78n/a7
Mar ’25n/a
DKK 543.91
0%
7.7%DKK 619.79DKK 484.78n/a7
Feb ’25DKK 549.60
DKK 543.91
-1.0%
7.7%DKK 619.79DKK 484.78n/a7
Jan ’25DKK 566.20
DKK 539.96
-4.6%
6.4%DKK 620.32DKK 485.19n/a9
Dec ’24DKK 545.00
DKK 536.24
-1.6%
6.5%DKK 619.97DKK 484.92n/a9
Nov ’24DKK 481.70
DKK 521.19
+8.2%
13.3%DKK 640.94DKK 421.48n/a9
Oct ’24DKK 432.40
DKK 528.15
+22.1%
12.6%DKK 640.16DKK 420.96n/a9
Sep ’24DKK 446.80
DKK 531.45
+18.9%
10.8%DKK 640.24DKK 460.35n/a10
Aug ’24DKK 509.40
DKK 534.51
+4.9%
11.0%DKK 639.74DKK 460.14n/a10
Jul ’24DKK 473.60
DKK 537.20
+13.4%
10.3%DKK 639.25DKK 459.80n/a10
Jun ’24DKK 507.00
DKK 536.46
+5.8%
10.3%DKK 639.41DKK 459.92n/a10
May ’24DKK 530.40
DKK 536.88
+1.2%
10.3%DKK 640.81DKK 460.06n/a10
Apr ’24DKK 521.00
DKK 530.14
+1.8%
12.3%DKK 640.70DKK 450.74n/a9
Mar ’24DKK 494.30
DKK 528.99
+7.0%
11.7%DKK 639.66DKK 450.01n/a10
Feb ’24DKK 508.00
DKK 513.00
+1.0%
10.6%DKK 619.78DKK 449.67DKK 549.6010
Jan ’24DKK 499.70
DKK 513.77
+2.8%
11.4%DKK 620.31DKK 424.91DKK 566.2011
Dec ’23DKK 447.60
DKK 459.23
+2.6%
11.0%DKK 550.42DKK 380.06DKK 545.0012
Nov ’23DKK 410.60
DKK 454.61
+10.7%
11.5%DKK 550.76DKK 380.33DKK 481.7013

Analyst Forecast: Target price is lower than the current share price.

Discover undervalued companies